Wium-Andersen Ida Kim, Wium-Andersen Marie Kim, Jørgensen Martin Balslev, Osler Merete
From the Psychiatric Center Ballerup, Ballerup, Denmark (I. Wium-Andersen); the Research Center for Prevention and Health, Glostrup Hospital, Glostrup, Denmark (I. Wium-Andersen, M. Wium-Andersen, Osler); the Psychiatric Center Frederiksberg, Frederiksberg, Denmark (M. Wium-Andersen); the Psychiatric Center Copenhagen, Department O, and Institute of Clinical medicine University of Copenhagen, Denmark (I. Wium-Andersen, K. Wium-Andersen, Jørgensen); and the Department of Public Health, Section of Social Medicine, University of Copenhagen, Denmark (Osler).
J Psychiatry Neurosci. 2017 Sep;42(5):320-330. doi: 10.1503/jpn160244.
Depression is a common complication after stroke, and inflammation may be a pathophysiological mechanism. This study examines whether anti-inflammatory treatment with acetylsalicylic acid (ASA), nonsteroid anti-inflammatory drugs (NSAIDs) or statins influence the risk of depression after stroke.
A register-based cohort including all patients admitted to hospital with a first-time stroke from Jan. 1, 2001, through Dec. 31, 2011, and a nonstroke population with a similar age and sex distribution was followed for depression until Dec. 31, 2014. Depression was defined as having a hospital contact with depression or having filled prescriptions for antidepressant medication. The associations between redeemed prescriptions of ASA, NSAIDs or statins with early- (≤ 1 year after stroke or study entry) and late-onset (> 1 year after stroke or study entry) depression were analyzed using Cox proportional hazard regression.
We identified 147 487 patients with first-time stroke and 160 235 individuals without stroke for inclusion in our study. Redeemed prescriptions of ASA, NSAIDs or statins after stroke decreased the risk for early-onset depression, especially in patients with ischemic or severe stroke. Patients who received a combination of anti-inflammatory treatments had the lowest risk for early-onset depression. On the other hand, use of ASA or NSAIDs 1 year after stroke increased the risk for late-onset depression, whereas statin use was associated with a tendency toward a decreased risk.
The study used prescription of antidepressant medication as a proxy measure for depression and did not include anti-inflammatory drugs bought over the counter.
Anti-inflammatory treatment is associated with a lower risk for depression shortly after stroke but a higher risk for late depression. This suggests that inflammation contributes differently to the development of depression after stroke depending on the time of onset.
抑郁症是中风后的常见并发症,炎症可能是其病理生理机制。本研究旨在探讨使用乙酰水杨酸(ASA)、非甾体抗炎药(NSAIDs)或他汀类药物进行抗炎治疗是否会影响中风后抑郁症的风险。
基于登记的队列研究纳入了2001年1月1日至2011年12月31日期间首次因中风入院的所有患者,以及年龄和性别分布相似的非中风人群,随访至2014年12月31日以观察抑郁症情况。抑郁症定义为有与抑郁症相关的医院就诊记录或有抗抑郁药物处方。使用Cox比例风险回归分析ASA、NSAIDs或他汀类药物的已兑现处方与早期(中风后或研究入组后≤1年)和迟发性(中风后或研究入组后>1年)抑郁症之间的关联。
我们确定了147487例首次中风患者和160235例非中风个体纳入本研究。中风后使用ASA、NSAIDs或他汀类药物的已兑现处方降低了早期抑郁症的风险,尤其是在缺血性或严重中风患者中。接受联合抗炎治疗的患者早期抑郁症风险最低。另一方面,中风后1年使用ASA或NSAIDs会增加迟发性抑郁症的风险,而使用他汀类药物有降低风险的趋势。
本研究使用抗抑郁药物处方作为抑郁症的替代指标,且未包括非处方购买的抗炎药物。
抗炎治疗与中风后不久抑郁症风险较低相关,但与迟发性抑郁症风险较高相关。这表明炎症对中风后抑郁症发生发展的影响因发病时间而异。